Financial News

Minnesota biotech firm Vyriad raises $29.5 million for cancer-fighting viruses

Vyriad Inc., a company that's engineering cancer-killing viruses, announced Tuesday it raised $29.5 million in Series B funding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Feedback